- Topic
8k Popularity
12k Popularity
34k Popularity
24k Popularity
7k Popularity
6k Popularity
69k Popularity
141k Popularity
70k Popularity
1744k Popularity
- Pin
- #Gate Ranks Top 4 Exchange#
Gate has reached the Top 4 global crypto derivatives exchanges on CoinMarketCap, with a 24-hour trading volume exceeding $15 billion. Enjoy some of the lowest fees in the industry—maker fees as low as 0.015%. Gate is committed to providing users with a more efficient and cost-effective trading experience, making it your top choice for crypto trading!
Start trading now:
👉 Spot Trading: https://www.gate.com/trade
👉 Alpha Trading: https://www.gate.com/alpha
👉 Futures Trading: https://www.gate.com/futures
💬 What derivatives or other products have you recently traded
- 🎉 CandyDrop 5.0: 5 BTC Mega Airdrop is here!
🎁 Total Prize Pool: 5 BTC
📈 Trade any futures pair ≥ 50,000 USDT to earn Candy
👥 Invite friends to unlock more BTC rewards
🗓️ Event Time: June 27, 9:00 – July 11, 9:00 (UTC)
🎯 Max reward per user: 0.01 BTC
👉 Join Now >> https://www.gate.com/candy-drop/detail/BTC-59
⚡ 100% real airdrop — limited time only!
- Gate Alpha 2nd Points Carnival Round 4 Hot Launch! Trade to Share $30,000 MORE & Alpha Points
Trade $MORE to unlock Listing Airdrops + $300K Points Prize Pool!
💰 Total Airdrop Volume: $30,000 MORE, Limited slots—first come, first served!
✅ Total Points: 2 Alpha Points per trade—accumulate points to share the $300K prize pool!
🔥Trade the Hottest On-Chain Assets First
For more information: https://www.gate.com/campaigns/1342alpha?pid=X&c=MemeBox&ch=vxDB0fQ5
- 📢 $MORE is launching on Gate Alpha!
Users will be able to trade Moonveil ( $MORE ) directly via Gate Alpha — Gate's one-stop on-chain trading portal.
🔥Trade the Hottest On-Chain Assets First
https://www.gate.com/alpha
- 🎁 Gate Alpha Airdrop Alert!
To celebrate the listing of $EGL1 on Gate Alpha @GateioAlpha
A limited-time airdrop campaign is now live — with 149,254 EGL1 up for grabs!
First Come, First Served
🔥Trade the Hottest On-Chain Assets First
For more information: https://www.gate.com/campaigns/1355?pid=X&ch=0cykUS3i
Lyon: Remains optimistic about the development of Stone Pharmaceutical Group, maintaining a "highly confident outperform the market" rating.
Jin10 data reported on May 30 that Lyon published a research report indicating that although the sales of Enbipusi from Shanghai Pharmaceuticals (01093.HK) faced challenges, the first quarter performance still met expectations, with a year-on-year net profit fall of 8.4%. It is believed that Shanghai Pharmaceuticals' profits have bottomed out in the first quarter. In addition to the market's focus on SYS6010, the management also revealed that there are two other products that will achieve potential licensing cooperation, each exceeding $5 billion in scale. Lyon expressed continued optimism about Shanghai Pharmaceuticals' development, believing that its early R&D pipeline is competitive globally and has a differentiated innovative drug platform, maintaining a "highly confident outperform the market" rating for Shanghai Pharmaceuticals, with a target price of HKD 13.8.